Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

January 13, 2022
Correction
Open Access

Correction to: An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Journal of Translational Medicine
Klaus J WirthFriedemann Paul
January 9, 2022
Review

Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19.

Journal of Cachexia, Sarcopenia and Muscle
Madu N SoaresRob C I Wüst
December 31, 2021
Open Access

Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Frontiers in Neurology
Dominic StanculescuJonas Bergquist
December 28, 2021

Assessment of systemic joint laxity in the clinical context: Relevance and replicability of the Beighton score in chronic fatigue.

Journal of Back and Musculoskeletal Rehabilitation
Gabriella BernhoffLina Bunketorp Käll
December 23, 2021

Post-Covid-19 Syndrome: Improvements in Health-Related Quality of Life Following Psychology-Led Interdisciplinary Virtual Rehabilitation.

Journal of Primary Care & Community Health
Sari HarenwallAmy Rachel Bland
December 11, 2021
Review

Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies.

Reviews in Medical Virology
Shin Jie Yong, Shiliang Liu
December 10, 2021

Breast implant illness: scientific evidence of its existence.

Expert Review of Clinical Immunology
J W Cohen TervaertM Osman
December 8, 2021
Preprint
Open Access

Long COVID Citizen Scientists - Developing a needs-based research agenda by persons affected by Long COVID

MedRxiv : the Preprint Server for Health Sciences
Sarah ZieglerM. A. Puhan
December 6, 2021
Review
Open Access

Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.

Frontiers in Immunology
Manuel Ruiz-PablosAintzane Zabaleta
December 6, 2021
Open Access

The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

Journal of Translational Medicine
Iñigo MurgaJosé-Vicente Lafuente
December 4, 2021

Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post-Coronavirus Disease.

JACC. Heart Failure
Donna M ManciniBenjamin H Natelson

Sign up to follow this feed and discover related papers.

Related Feeds

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Epigenetics of Myotonic Dystrophy

Myotonic Dystrophy is an autosomal dominant neuromuscular disorder associated with the expansion of CTG trinucleotide repeats in the 3’ untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. Here is the latest research focusing on epigenetic modifications in myotonic dystrophy.

© 2022 Meta ULC. All rights reserved
/feed-previews/chronic-fatigue-syndrome/68dbfb0f-e560-4919-bf8f-e99721cadd22